Actym Therapeutics’ proprietary STACT™ biological platform is highly modular, multi-faceted and enables cell-, microenvironment-, and tissue-targeted delivery of large, multiplexed plasmid payloads via systemic administration. Expression of payloads, including therapeutic RNA, protein, peptide, and gene editing effectors, can be enabled in either the bacterial vehicle or targeted human cells. Additionally, its engineered auxotrophy allows for […]